Overview
This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer.
Description
OUTLINE: This is an observational study.
Patients undergo blood sample collection and complete surveys on study. Patients' medical records are also reviewed.
Eligibility
Inclusion Criteria:
- * Subjects will have or had ovarian cancer and are on or have completed PARPi
maintenance therapy
- Or have been diagnosed with ovarian cancer as well as clonal hematopoiesis of indeterminate potential
- Have a life expectancy of greater than 6 months
Exclusion Criteria:
- * Individuals with a life expectancy of less than 6 months